Carlier Group receives $3.7 M from the NIH to develop safe drugs that combat the persistent malaria parasite at multiple life stages
Carlier Group has two openings!
Chemical Biology Post-Doctoral Associate
Medicinal Chemistry Post-Doctoral Associate
Medicinal Chemistry for Global Public Health
Malaria is a scourge in the developing world, affecting 200 million people and killing nearly 450,000 annually. To treat this infected population, new antimalarial drugs are urgently needed. As such, we are taking a two-pronged strategy to reduce malaria transmission and mortality.
(hover with cursor to stop slideshow)
May 26-27, 2021
Zoom, with Virtual Reality Poster Session